Free Trial
OTCMKTS:KNBWY

Kirin Q3 2026 Earnings Results & Report

Kirin logo
$18.79 -0.51 (-2.62%)
As of 11:09 AM Eastern

Kirin beat analyst earnings expectations in its Q3 2026 results, released November 11, 2026. The company reported EPS of $0.36 versus the $0.2707 consensus estimate.

Earnings Announcement Details

Quarter
Q3 2026
Time
After Market Closes

Kirin EPS Results

Actual EPS
$0.36
Consensus EPS
$0.2707
Beat/Miss
Beat by +$0.0893
One Year Ago EPS
N/A
EPS Beat Rate
4 of last 7 quarters

Kirin Revenue Results

Actual Revenue
N/A
Expected Revenue
$4.04 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Kirin Q3 2026 Earnings FAQ

Kirin (OTCMKTS:KNBWY) reported earnings of $0.36 per share for Q3 2026, beating the consensus estimate of $0.2707. The report was announced on Wednesday, November 11, 2026.

Kirin Earnings Headlines

Kirin (KNBWY) Set to Announce Earnings on Tuesday
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel
See More Kirin Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Kirin? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kirin and other key companies, straight to your email.

About Kirin

Kirin (OTCMKTS:KNBWY) Holdings Company, Limited is a Japanese company with businesses in beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks and other nonalcoholic products, with brands sold in Japan and international markets.

The company traces its roots to the Japan Brewery Company, established in 1885, and adopted the Kirin Brewery name in 1907. Today, its pharmaceutical business includes Kyowa Kirin, which develops and sells medicines, while its health science activities include products such as supplements and functional foods.

Kirin is headquartered in Tokyo and serves customers across Japan and overseas, including markets in Asia-Pacific and other regions through its operating companies and businesses. Its portfolio spans consumer beverages as well as health-related products and medicines.

View Kirin Profile